EP300 and chronic obstructive pulmonary disease: In turn, the inhibition of the two interactions of DDIT3 identified by MuXTalk, CUL1 and EP300, has been shown to reduce fibroblast proliferation in chronic obstructive pulmonary disease (COPD) and IPF (53,54).